OTCMKTS:PCLOF PharmaCielo (PCLOF) Stock Price, News & Analysis $0.03 -0.01 (-13.64%) As of 03:49 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChart About PharmaCielo Stock (OTCMKTS:PCLOF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get PharmaCielo alerts:Sign Up Key Stats Today's Range$0.03▼$0.0450-Day Range$0.03▼$0.0552-Week Range$0.00▼$0.12Volume1,100 shsAverage Volume58,716 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview PharmaCielo Ltd. is a Canadian cannabis company focused on the cultivation, processing and commercial development of medicinal cannabis products. Through its Colombian subsidiary, PharmaCielo Colombia Holdings S.A.S., the company has developed operations in Colombia, where it grows cannabis and produces cannabis-derived extracts and related ingredients. The company has primarily pursued a business-to-business model, supplying cannabis oils, extracts and other cannabinoid products to pharmaceutical, nutraceutical and consumer packaged-goods companies. Its product development activities have included standardized cannabinoid formulations and white-label or private-label solutions for international markets, subject to applicable regulatory approvals. PharmaCielo was established in the mid-2010s and has emphasized Colombia as a production base because of the country's climate and regulatory framework for medical cannabis. The company has sought to serve international medical-cannabis and wellness markets, although the availability of its products and the scope of its commercial operations may vary by jurisdiction.AI Generated. May Contain Errors. Read More Receive PCLOF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PharmaCielo and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PCLOF Stock News HeadlinesPharmaCielo Pays Debenture Interest in Shares Ahead of April AGMMarch 17, 2026 | tipranks.comPharmaCielo Announces Annual General Meeting and Intention to Issue Interest SharesFebruary 17, 2026 | finance.yahoo.comDid you grab your copy yet?Bill Poulos's Top 10 Stocks to Buy This Quarter report is still available free, but not for long. Every quarter he swaps in a brand-new list, and once the new edition launches, this one disappears. Investors who want a current snapshot of his picks should grab a copy now and save it before the switch happens.October 16 at 1:00 AM | Profits Run (Ad)PharmaCielo Completes La Margarita Land Sale, Repays Banco Agrario Loan, Strengthens Balance Sheet, Completes AuditOctober 6, 2025 | financialpost.comFPharmaCielo Completes La Margarita Land Sale, Repays Banco Agrario Loan, Strengthens Balance Sheet, Completes AuditOctober 6, 2025 | globenewswire.comPharmaCielo Faces Cease Trade Order Amid Financial Filing DelayAugust 24, 2025 | theglobeandmail.comPharmaCielo Ltd. (PCLOF)December 26, 2024 | finance.yahoo.comPharmaCielo Cannabis Co. Reports 270% YoY Increase In Q3 Revenue, Confident About Profitability In 2025December 2, 2024 | benzinga.comSee More Headlines PCLOF Stock Analysis - Frequently Asked Questions How have PCLOF shares performed this year? PharmaCielo's stock was trading at $0.0372 at the beginning of the year. Since then, PCLOF shares have decreased by 13.2% and is now trading at $0.0323. How do I buy shares of PharmaCielo? Shares of PCLOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of PharmaCielo own? Based on aggregate information from My MarketBeat watchlists, some other companies that PharmaCielo investors own include Innovative Industrial Properties (IIPR), NIO (NIO), Proto Labs (PRLB), Cresco Labs (CRLBF), Curaleaf (CURLF), Green Organic Dutchman (TGODF) and Canopy Growth (CGC). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:PCLOF CIKN/A Webwww.pharmacielo.com Phone(416) 562-3220FaxN/AEmployees268Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (OTCMKTS:PCLOF) was last updated on 10/16/2026 by MarketBeat.com Staff. From Our PartnersElon Musk’s 4th Wealth Window Set to Open by October 30Jeff Brown, the analyst who flagged Bitcoin, Tesla, and Nvidia early, is tracking Elon Musk's next move. He po...Brownstone Research | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and ...Porter & Company | SponsoredSpaceX minted 4400 millionaires in a single daySpaceX minted 4,400 millionaires in a single day, and Tesla has turned more than 5,000 employees into milliona...Behind the Markets | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredUndiscovered Sub-$1 Gold-Silver Royalty Stock Takes FlightA small-cap gold and silver royalty company is generating record revenue from producing mines, yet shares stil...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PharmaCielo Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share PharmaCielo With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.